Guided Imagery in Perimenopausal Women

The Effect of Guided Imagery on Quality of Life and Insomnia in Perimenopausal Women

NCT07176611•Menekşe Nazlı AKER

Summary

The study will be conducted in two groups as guided imagery and control. Participants will be approached at the Public Education Center. After perimenopausal women are evaluated according to eligibility criteria, those who are eligible will be informed about the research and written informed consent will be obtained from those who agree. Random assignment of women to the study groups will be carried out using randomization.

Eligibility

Age

45 - No limit years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•Being between 45-59 years of age
•Being in the perimenopausal period according to the Stages of Reproductive Aging Workshop (STRAW) criteria (stage +1 or +2)
•* Early menopausal transition (STRAW -2): menstrual cycle length varies by 7 days or more
•* Late menopausal transition (STRAW -1): amenorrhea lasting 60 days or longer
•Having entered natural menopause in postmenopausal women
•Scoring above 10 on the Women's Health Initiative Insomnia Rating Scale
•Owning a smartphone
•Ability to understand and speak Turkish
•No hearing impairment
•Volunteering to participate in the study

Exclusion Criteria

•Having received or currently receiving hormone replacement therapy
•Alcohol use
•Practicing another mind-body intervention
•Having a diagnosed disease that may cause sleep disorders and receiving medical treatment
•Having a diagnosed disease that may significantly affect quality of life and receiving medical treatment

Locations (1)

Akdağmadeni Public Education Center

Yozgat, Turkey (Türkiye)

Key Dates

Start Date

September 15, 2025

Primary Completion Date

November 30, 2025

Completion Date

November 30, 2025

Last Updated

December 8, 2025

Enrollment

ACTUAL participants

Conditions

Perimenopausal Women

Interventions

Guided imagery

OTHER

A Trial to Investigate the Accuracy of a Wearable Device in Collecting Data Related to Perimenopausal Symptoms in Women

NCT07022925

PerimenopausePerimenopausal Depression+6 more

View study

COMPLETEDNA

Serum Levels of C Type Natriuretic Peptide in Different Reproductive Periods

NCT04000815

Serum CNP LevelsHealthy Reproductive Age Women+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 8, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions